Exercise and Venous Compression on Upper Airway Resistance in Obese Teenagers With OSA (OBESOMAC)

Effects of Exercise and Venous Compression on Upper Airway Resistance in Obese Teenagers With Obstructive Sleep Apnea Syndrome

The purpose of this study is to assess the effects of physical exercise, associated or not with venous compression of the leg, on obstructive sleep apnea (OSA) severity and upper airway resistance in obese teenagers. Half of the participants will undergo physical exercise and compression socks program, and the other half of subjects will undergo physical exercise program without compression socks.

Study Overview

Detailed Description

Obesity is an important factor of OSA development in children and teenagers, and physical activity is a relevant alternative to promote OSA decrease with ou without weight loss.

Physical activity, beyond the improvement of body composition and exercise cardiorespiratory capacity, restricts fluid retaining in the lower limb of the leg by the activation of musculovenous pump. Fluid retaining is involved in OSA severity because of nocturnal fluid shift from legs to rostral zone which promotes pharyngeal oedema development and upper airway collapsibility.

It has been previously shown that venous compression leads to beneficial fluid regulation in OSA subjects and appears as an efficient tool in OSA management.

To the investigators knowledge no study assess the impact of the cumulative effect of physical and venous compression program on upper airway resistances in obese teenager with OSA.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Salins-les-Bains, France, 39110
        • Centre de soins de suite et de réadaptation La Beline

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Obese adolescents (BMI > 97th percentile),
  • patients aged from 12 to 17 years old, (born between 07/01/2003 and 09/01/1197),
  • enrolled in a pediatric obesity center with diet and physical activity programs and psychological management,
  • without observed tonsils hypertrophy (Mallampati and Friedman scores),
  • without contraindication for bioimpedance analysis, acoustic method and stain gauge plethysmography,
  • with physical activity certificate issued by a cardiologist
  • covered by the national insurance scheme of his/her legal representative,
  • having signed, as well as his(her) legal representative, the informed consent of participation.

Exclusion Criteria:

  • Non obese adolescents (BMI < 97th percentile)
  • patients aged under 12 or over 17 years old,
  • not enrolled in a pediatric obesity center with diet and physical activity programs and psychological management,
  • with observed tonsils hypertrophy (Mallampati and Friedman scores),
  • with contraindication for bioimpedance analysis, acoustic method and stain gauge plethysmography,
  • without physical activity certificate issued by a cardiologist
  • uncovered by the national insurance scheme of his/her legal representative,
  • not having signed, as well as his(her) legal representative, the informed consent of participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interventional group
Physical activity program coupled with compression socks wearing during 3 months.

Venous compression leads to beneficial fluid regulation in OSA participants and appears as an efficient tool in OSA management.

To the investigators knowledge no study assess the impact of the cumulative effect of physical and venous compression program on upper airway resistances in obese teenager with OSA.

Active Comparator: control group
Physical activity program without compression socks during 3 months.
Standard obesity care with physical activity program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Obstructive sleep apnea severity at 3 months.
Time Frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)
Obstructive Sleep Apnea change will be assessed with polysomnography system at baseline and after three months
This study includes 2 assessments : baseline (T0) and 3 months (T3)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Upper airway resistances
Time Frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)
upper airway resistance will be assessed by acoustic method
This study includes 2 assessments : baseline (T0) and 3 months (T3)
Fluid shift
Time Frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)
fluid shift will be assessed by bioimpedance analysis
This study includes 2 assessments : baseline (T0) and 3 months (T3)
Calf and neck circumferences
Time Frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)
Calf and neck circumferences will be assessed with nonelastic tape
This study includes 2 assessments : baseline (T0) and 3 months (T3)
Calf and neck circumferences
Time Frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)
Calf and neck circumferences will be assessed by plethysmography
This study includes 2 assessments : baseline (T0) and 3 months (T3)
Anthropometric parameters
Time Frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)
weight, height, waist and hip circumferences (body weight scale, standing stadiometer and non-elastic tape)
This study includes 2 assessments : baseline (T0) and 3 months (T3)
Body composition
Time Frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)
fat mass, fat free mass ( by bioimpedance analysis)
This study includes 2 assessments : baseline (T0) and 3 months (T3)
Pulmonary function during exercise
Time Frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)
Incremental maximal exercise in cycling ergometer with respiratory gas assessment (metamax)
This study includes 2 assessments : baseline (T0) and 3 months (T3)
Metabolic responses
Time Frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)
Glucose, LDL-Cholesterol, HDL-Cholesterol, Total Cholesterol, Triglycerides (ELISA and RIA technics)
This study includes 2 assessments : baseline (T0) and 3 months (T3)
Hormonal responses
Time Frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)
Insulin, leptin, adiponectin, catecholamines (ELISA and RIA technics)
This study includes 2 assessments : baseline (T0) and 3 months (T3)
Inflammatory responses
Time Frame: This study includes 2 assessments : baseline (T0) and 3 months (T3)
C-reactive protein (ELISA and RIA technics)
This study includes 2 assessments : baseline (T0) and 3 months (T3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 27, 2015

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

June 1, 2016

Study Registration Dates

First Submitted

July 22, 2015

First Submitted That Met QC Criteria

October 26, 2015

First Posted (Estimate)

October 27, 2015

Study Record Updates

Last Update Posted (Actual)

January 24, 2018

Last Update Submitted That Met QC Criteria

January 22, 2018

Last Verified

January 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Apnea, Obstructive

Clinical Trials on Interventional group

Subscribe